Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Stem cells Stories

2014-02-25 23:22:28

The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue) - http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html. (PRWEB) February 25, 2014 This report studies “Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding,...

2014-02-25 14:21:48

Our cells don’t live in a vacuum. They are surrounded by a complex, nurturing matrix that is essential for many biological functions, including growth and healing. In all multicellular organisms, including people, cells make their own extracellular matrix. But in the lab, scientists attempting to grow tissue must provide a scaffold for cells to latch onto as they grow and proliferate. This engineered tissue has potential to repair or replace virtually any part of our bodies....

2014-02-25 08:30:32

BOTHELL, Wash., Feb. 25, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFSD), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or the "Company"), today announced that Natick, Massachusetts-based Parcell Laboratories has adopted BioLife's CryoStor clinical grade cell and tissue freeze media for use in future clinical trials...

2014-02-25 08:30:28

LOS ANGELES, Feb. 25, 2014 /PRNewswire/ -- FamilyCord, a subsidiary of California Cryobank, now provides direct cord blood and cord tissue services to Venezuelan families and has assumed management of clients of Cordon de Vida, one of Venezuela's largest cord blood banks. FamilyCord has already been processing and storing Cordon de Vida's cord blood units at their state-of-the-art facility in Los Angeles, California. "We have developed a wonderful working relationship with the...

2014-02-24 12:26:25

GRAPEVINE, Texas, Feb. 24, 2014 /PRNewswire-USNewswire/ -- Just 10 years ago, older patients were typically considered ineligible to receive a blood or bone marrow transplantation (BMT) to treat their blood cancer, but today, patients age 65 and older not only qualify for BMT therapy but are the fastest growing group of recipients. This was reported at the American Society for Blood and Marrow Transplantation (ASBMT) annual meeting as it celebrates its 20(th) anniversary and reflects...

science laboratory
2014-02-24 05:23:59

Gladstone Institutes Joint Gladstone-UCSF study highlights novel reprogramming method; offers new hope for treating liver failure SAN FRANCISCO, CA—February 23, 2014 — The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells and even neurons. However, a method to generate cells that are fully mature—a crucial prerequisite for life-saving therapies—has proven far more difficult. But now,...

2014-02-21 23:02:24

Okyanos Selects Cytori To Provide Equipment And Supplies To Treat Patients With Coronary Artery Disease Using Their Own Adult Stem Cells Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, and Cytori Therapeutics have announced that they have established a ten year supply agreement for the Celution™ System family of...

2014-02-21 23:01:55

A new study released today in STEM CELLS Translational Medicine shows that many patients with defects to the skull, face or jaw bone might benefit from reconstructive surgery combining stem cells taken from adipose (fat) tissue seeded on resorbable scaffolds. Durham, NC (PRWEB) February 21, 2014 A new study released today in STEM CELLS Translational Medicine shows that many patients with defects to the skull, face or jaw bone might benefit from reconstructive surgery combining stem cells...

2014-02-20 23:25:03

A European study of compounds designed to stimulate stem cells finds that biologically similar versions work as well as the original. Raleigh, NC (PRWEB) February 20, 2014 A study published in the journal Theranostics and reported by the Non-Hodgkin’s Lymphoma Center finds that a class of drugs that stimulate stem cell production in patients and donors is safe to use. The drugs are biologically similar to granulocyte colony stimulating factor (G-CSF), a human glycoprotein that...

2014-02-20 23:00:18

MarketReportsOnline.com offers "India Cord Blood Stem Cell Banking Market" report to its research store. Dallas, Texas (PRWEB) February 21, 2014 Cord Blood Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued around US$ 60 Million in 2013 and further expected to surpass US$ 400 Million by 2018. The current cord blood stem cell preservation level for new born baby is below...